2026 NYC Neuromodulation Conference
Meet SEBERS Medical at the NYC Neuromodulation Conference
Join SEBERS Medical at the NYC Neuromodulation Conference, one of the world’s leading conferences dedicated to neuromodulation, brain stimulation, and neurotechnology. Bringing together neuroscientists, clinicians, engineers, and innovators from around the globe, the conference focuses on the latest advances in Transcranial Magnetic Stimulation (TMS), brain-computer interfaces, EEG-guided neuromodulation, computational modeling, and next-generation brain stimulation technologies.
At this year’s conference, SEBERS Medical is proud to present Blossom²—our next-generation research TMS platform developed to enable groundbreaking investigations into neuroplasticity, adaptive neuromodulation, and personalized brain stimulation.
Blossom² – Designed for the Future of Neuroscience
Blossom² combines exceptional hardware performance with a fully programmable software architecture, giving researchers the flexibility to develop, reproduce, and optimize advanced stimulation paradigms within a single platform.
Key features include:
- Fingerprint TMS™ for individualized stimulation based on each subject’s neurophysiological characteristics
- Single-pulse, paired-pulse, rTMS, Theta Burst Stimulation (TBS), Quadri-Pulse Stimulation (QPS), individualized iQPS, and freely programmable stimulation protocols
- Ultra-fine 100 µs timing resolution for highly precise pulse timing
- Programmable burst architectures with individually adjustable pulse intervals
- Stimulation frequencies up to 1,000 Hz within burst sequences
- AI-ready architecture designed for future intelligent protocol optimization
- Open interfaces for EEG, EMG, neuronavigation systems, and external research hardware
- Advanced trigger input and output capabilities for synchronized multimodal experiments
- Flexible software environment supporting custom protocol development and future research applications
These capabilities make Blossom² an ideal platform for investigating:
- Neuroplasticity and cortical physiology
- I-wave-dependent stimulation
- Adaptive neuromodulation
- Brain-state dependent stimulation
- Closed-loop neuromodulation
- Biomarker-guided stimulation
- Brain connectivity and network dynamics
- Personalized stimulation paradigms
- Translational neuroscience
Prepared for the Next Generation of Closed-Loop TMS
As neuroscience continues to move toward intelligent and adaptive brain stimulation, Blossom² has been designed to provide the technological foundation for future closed-loop TMS research.
Its open architecture enables seamless integration with external physiological signals, including EEG and EMG, allowing researchers to synchronize stimulation with brain activity and investigate future applications such as AI-assisted protocol optimization, biomarker-driven stimulation, and adaptive neuromodulation strategies.
TMS Pilot™ – Precision Where It Matters
Visitors will also experience the TMS Pilot™, our innovative coil-mounted positioning system designed to improve both clinical and research workflows.
Unlike conventional positioning methods, the TMS Pilot allows users to visualize the stimulation target directly beneath the coil. Real-time visual guidance enables fast, intuitive, and highly reproducible coil placement while simplifying repositioning during longitudinal studies and repeated treatment sessions. The result is improved targeting consistency, greater workflow efficiency, and increased confidence for both researchers and clinicians.
Visit SEBERS Medical
Whether you are developing the next generation of brain stimulation technologies, investigating neuroplasticity, advancing EEG-guided neuromodulation, or exploring future closed-loop TMS applications, we invite you to visit SEBERS Medical at the NYC Neuromodulation Conference.
Discover how Blossom² and the TMS Pilot™ are enabling researchers to move beyond conventional stimulation protocols toward a new era of programmable, adaptive, and personalized neuromodulation.
SEBERS Medical – From Clinical Excellence to the Future of Neuroplasticity.